Vaccinens virkning blev vurderet i én hovedundersøgelse, hvori der deltog 2 654 voksne, hvoraf ca. halvdelen var ældre (over 60 år).
The vaccine’ s effectiveness was assessed in one main study involving 2,654 adults, around half of whom were elderly (over 60 years of age).